UK Medical Journal Publishes Issue Analyzing Israel 3 Years After Denouncing It
JERUSALEM (JTA) — The British medical journal The Lancet published a special issue on Israel three years after publishing an open letter that accused Israel of committing war crimes in Gaza.
The special issue, titled “Health in Israel: Progress and Challenges in a Region of Conflict,” was unveiled Monday in Tel Aviv. The issue is part of The Lancet’s series of country analyses investigating progress toward universal health coverage, and explores the unique aspects of health and health care delivery in Israel. The papers, authored by academics and policymakers in Israel, offer constructive recommendations for strengthening the country’s health care system, improving health and addressing health inequalities in Israel.
In the August 2014 issue of the Lancet, several dozen doctors signed an open letter accusing Israel of a “massacre” and “vicious war crimes” during its war against Hamas.
The Lancet’s editor-in-chief, Dr. Richard Horton, visited Israel that October and then wrote in an editorial that he regretted publishing the letter.
In the wake of the Gaza letter, the journal issued new guidelines to deal with “submissions that lie at the difficult intersection of medicine and politics.”
A message from our CEO & publisher Rachel Fishman Feddersen
I hope you appreciated this article. Before you move on, I wanted to ask you to support the Forward’s award-winning journalism during our High Holiday Monthly Donor Drive.
If you’ve turned to the Forward in the past 12 months to better understand the world around you, we hope you will support us with a gift now. Your support has a direct impact, giving us the resources we need to report from Israel and around the U.S., across college campuses, and wherever there is news of importance to American Jews.
Make a monthly or one-time gift and support Jewish journalism throughout 5785. The first six months of your monthly gift will be matched for twice the investment in independent Jewish journalism.
— Rachel Fishman Feddersen, Publisher and CEO